Biogen
-
Artes and Rhein Minapharm Continue Joint Product Development
Artes Biotechnology and Rhein Minapharm Biogenetics have jointly announced the production of a target of a therapeutic protein. The former applied its Hansenula technology platform and know-how to the generation of a therapeutic protein that was cho…
Biogen | 01 January 2010
-
Neurimmune Therapeutics Advances Alzheimer’s Program into Preclinical Development
Neurimmune Therapeutics has announced that its lead human therapeutic antibody for Alzheimer’s disease has advanced into preclinical development, triggering milestone payments of an undisclosed amount from Biogen Idec. The alliance between the …
Biogen | 19 August 2009
-
BioGenes Becomes Partner for Dementia Research Project
BioGenes, a specialist in sophisticated antibody development, has been chosen as a partner of cNEUPRO. The latter is an EU funded research project to analyze neurodegenerative diseases and discover novel biomarkers, to improve early and differential …
Biogen | 23 February 2009
-
India Readies for Generic Biologics Markets
Indian companies poised to enter global markets with generic biologics.
Biogen | 01 October 2008
